MRTX News and Press, Mirati Therapeutics Inc. From 11/09/19

Now is a great time to have biotech stocks in your portfolio. While biotech investing can be scary, because the small-cap companies are often unprofitable research-and-development labs, this is also where a lot of the cutting-edge science is happening. Let's see how Mirati Therapeutics (NA...

Biotech Pulse Biotech finally has a pulse. The improving appetite for risk has resuscitated the moribund biotechs and pharma (biopharma) groups. The Nasdaq Biotech ( IBB ) and the S&P Biotech ( XBI ) indexes have begun their advance from their year-to-date lows recorded earlier in Octo...

Mirati Therapeutics (NASDAQ: MRTX ): Q3 GAAP EPS of -$1.38 misses by $0.13 . More news on: Mirati Therapeutics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...

SAN DIEGO , Nov. 4, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter ended September 30, 2019 . Recent Corporate Updates: Presented early clinical data from the Ph...

Look out, cancer: There could be two new sheriffs in town. Not long ago, Amgen (NASDAQ: AMGN) presented early results from the first clinical trial with easy-to-swallow capsules that fight cancer in a way previously considered impossible. More recently, Mirati Therapeutics (NASDAQ: MRTX) ...

The biotech version of David vs. Goliath just got more interesting, with the $3.7-billion-market-cap Mirati Therapeutics (NASDAQ: MRTX) posting data this week for its KRAS inhibitor MRTX849 suggesting it can be competitive with AMG 510 from Amgen (NASDAQ: AMGN) , which weighs in at a ma...

Shares of Mirati Therapeutics   (NASDAQ: MRTX) , a clinical-stage biopharmaceutical company, are rising again today. This time, the stock is soaring in response to highly anticipated clinical trial data produced by Mirati, instead of by a similar program from  Amgen   (NASDA...

Gainers: Wins Finance Holdings (NASDAQ: WINS ) +49% . Synthesis Energy Systems (NASDAQ: SES ) +36% . Amkor Technology (NASDAQ: AMKR ) +30% . PG&E (NYSE: PCG ) +20% . Texas Roadhouse (NASDAQ: TXRH ) +19% . Talos Energy (NYSE: TALO ) +16% . Harmonic (NASDAQ: HLIT ) +15% . Na...

Amkor Technology (NASDAQ: AMKR ) +16%  on Q3 results . More news on: Amkor Technology, Inc., Mirati Therapeutics, Inc., Globus Maritime Limited, Stocks on the move, Read more ...

Mirati Therapeutics (NASDAQ: MRTX ) is up 22.2% after hours following results from its Phase 1/2 trial of MRTX849 . More news on: Mirati Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...